Compare Biocon with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs ALKEM LABORATORIES - Comparison Results

BIOCON      Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON ALKEM LABORATORIES BIOCON /
ALKEM LABORATORIES
 
P/E (TTM) x 32.1 24.1 133.3% View Chart
P/BV x 3.8 5.8 65.8% View Chart
Dividend Yield % 0.3 0.8 30.8%  

Financials

 BIOCON    ALKEM LABORATORIES
EQUITY SHARE DATA
    BIOCON
Mar-19
ALKEM LABORATORIES
Mar-20
BIOCON /
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs7072,720 26.0%   
Low Rs5541,660 33.4%   
Sales per share (Unadj.) Rs91.9697.9 13.2%  
Earnings per share (Unadj.) Rs16.796.1 17.4%  
Cash flow per share (Unadj.) Rs24.2117.3 20.6%  
Dividends per share (Unadj.) Rs1.0025.00 4.0%  
Dividend yield (eoy) %0.21.1 13.9%  
Book value per share (Unadj.) Rs101.6515.2 19.7%  
Shares outstanding (eoy) m600.00119.57 501.8%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x6.93.1 218.6%   
Avg P/E ratio x37.722.8 165.6%  
P/CF ratio (eoy) x26.118.7 139.7%  
Price / Book Value ratio x6.24.3 146.0%  
Dividend payout %6.026.0 23.0%   
Avg Mkt Cap Rs m378,330261,879 144.5%   
No. of employees `0006.114.3 42.8%   
Total wages/salary Rs m11,65315,055 77.4%   
Avg. sales/employee Rs Th8,994.35,822.6 154.5%   
Avg. wages/employee Rs Th1,900.71,050.5 180.9%   
Avg. net profit/employee Rs Th1,635.3802.0 203.9%   
INCOME DATA
Net Sales Rs m55,14483,444 66.1%  
Other income Rs m1,4441,042 138.6%   
Total revenues Rs m56,58884,486 67.0%   
Gross profit Rs m15,88314,734 107.8%  
Depreciation Rs m4,4782,528 177.2%   
Interest Rs m709651 109.0%   
Profit before tax Rs m12,14012,598 96.4%   
Minority Interest Rs m90-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,1231,105 192.2%   
Profit after tax Rs m10,02611,493 87.2%  
Gross profit margin %28.817.7 163.1%  
Effective tax rate %17.58.8 199.4%   
Net profit margin %18.213.8 132.0%  
BALANCE SHEET DATA
Current assets Rs m48,22854,960 87.8%   
Current liabilities Rs m30,37632,433 93.7%   
Net working cap to sales %32.427.0 119.9%  
Current ratio x1.61.7 93.7%  
Inventory Days Days6880 85.8%  
Debtors Days Days8672 118.5%  
Net fixed assets Rs m64,13032,710 196.1%   
Share capital Rs m3,000239 1,254.7%   
"Free" reserves Rs m57,98061,368 94.5%   
Net worth Rs m60,98061,607 99.0%   
Long term debt Rs m15,7661,592 990.1%   
Total assets Rs m121,92499,433 122.6%  
Interest coverage x18.120.4 89.0%   
Debt to equity ratio x0.30 1,000.3%  
Sales to assets ratio x0.50.8 53.9%   
Return on assets %8.812.2 72.1%  
Return on equity %16.418.7 88.1%  
Return on capital %16.821.0 79.9%  
Exports to sales %28.119.1 147.4%   
Imports to sales %18.93.0 633.8%   
Exports (fob) Rs m15,50615,917 97.4%   
Imports (cif) Rs m10,3992,483 418.8%   
Fx inflow Rs m15,50616,061 96.5%   
Fx outflow Rs m10,3992,483 418.8%   
Net fx Rs m5,10713,578 37.6%   
CASH FLOW
From Operations Rs m11,5465,851 197.3%  
From Investments Rs m-7,138-7,414 96.3%  
From Financial Activity Rs m-2,417792 -305.4%  
Net Cashflow Rs m2,103-731 -287.6%  

Share Holding

Indian Promoters % 40.4 66.9 60.4%  
Foreign collaborators % 20.6 0.0 -  
Indian inst/Mut Fund % 8.4 33.1 25.4%  
FIIs % 10.7 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 19.9 0.0 -  
Shareholders   109,995 68,381 160.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   UNICHEM LAB  AUROBINDO PHARMA  STERLING BIOTECH  GLENMARK PHARMA  SUN PHARMA  

Compare BIOCON With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty End Flat; Asian Paints, UPL & ITC Among Top Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views on News

BIOCON Announces Quarterly Results (3QFY21); Net Profit Down 19.7% (Quarterly Result Update)

Jan 25, 2021 | Updated on Jan 25, 2021

For the quarter ended December 2020, BIOCON has posted a net profit of Rs 2 bn (down 19.7% YoY). Sales on the other hand came in at Rs 19 bn (up 5.9% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (2QFY21); Net Profit Down 23.9% (Quarterly Result Update)

Oct 29, 2020 | Updated on Oct 29, 2020

For the quarter ended September 2020, BIOCON has posted a net profit of Rs 2 bn (down 23.9% YoY). Sales on the other hand came in at Rs 17 bn (up 11.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (3QFY20); Net Profit Up 1.2% (Quarterly Result Update)

Jan 24, 2020 | Updated on Jan 24, 2020

For the quarter ended December 2019, BIOCON has posted a net profit of Rs 2 bn (up 1.2% YoY). Sales on the other hand came in at Rs 17 bn (up 13.5% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (2QFY20); Net Profit Down 30.5% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, BIOCON has posted a net profit of Rs 3 bn (down 30.5% YoY). Sales on the other hand came in at Rs 16 bn (up 19.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (1QFY20); Net Profit Down 11.5% (Quarterly Result Update)

Jul 29, 2019 | Updated on Jul 29, 2019

For the quarter ended June 2019, BIOCON has posted a net profit of Rs 1 bn (down 11.5% YoY). Sales on the other hand came in at Rs 5 bn (down 57.2% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

More Views on News

Most Popular

Is Intraday Trading For You?(Fast Profits Daily)

May 13, 2021

Do you think you have what it takes to be an intraday trader? Find out in this video.

My Secret to Find Breakthrough Stocks(Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

Are the Stock Markets Deaf to Covid Agony?(Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

The Key to Profit from India's EV Revolution(Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON SHARE PRICE


May 14, 2021 (Close)

TRACK BIOCON

BIOCON - ABBOTT INDIA COMPARISON

COMPARE BIOCON WITH

MARKET STATS